| ||||||||||||||
|
|
|||||||||||||

*Edwards Laboratories #93A-118–7F, University of Alabama Medical Center, Birmingham, Alabama 35294.
American Optical #5145 pressure transducers, University of Alabama Medical Center, Birmingham, Alabama 35294.
Abstract
Following intravenous injection of 0.3 mg/kg of etomidate, the only noteworthy change in measured cardiovascular parameters was a 10 percent increase in heart rate. This suggests relatively stable cardiovascular response associated with administration of this new nonbarbiturate anesthesia induction agent.
This article has been cited by other articles:
![]() |
J. S. Savino and A. T. Cheung Cardiac Anesthesia Card. Surg. Adult, January 1, 2008; 3(2008): 281 - 314. [Full Text] |
||||
![]() |
J. S. Savino, T. F. Floyd, and A. T. Cheung Cardiac Anesthesia Card. Surg. Adult, January 1, 2003; 2(2003): 249 - 281. [Full Text] |
||||
![]() |
J. Sprung, M. L. Ogletree-Hughes, and C. S. Moravec The Effects of Etomidate on the Contractility of Failing and Nonfailing Human Heart Muscle Anesth. Analg., July 1, 2000; 91(1): 68 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Avramov and P. F. White Etomidate: Its Pharmacologic and Physiologic Effects Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1997; 1(2): 132 - 141. [PDF] |
||||
|